Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Medical Developments International.
RELATED STOCKHEAD STORIES
Experts
CRITERION: Gains without pains? Maybe tackle these sporting injury stocks instead
Experts
ScoPo’s Powerplays: Taps on again with ASX health stocks in BIG capital raises
Experts
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks – Morgans reviews quarterly results
Health & Biotech
ASX Health Stocks: Emyria takes its MDMA-inspired drugs to the next level
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month
News
ASX Small Cap Lunch Wrap: Who’s looking for a ‘Tyrant Lizard Queen’ today?
Health & Biotech
ASX Health Stocks: MVP’s ‘green whistle’ has finally got to Phase 3 in the US after FDA decision
Health & Biotech
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
Health & Biotech
Dr Boreham’s Crucible: Can fans of the ‘green whistle’ breathe easier as (if) Covid fades away?
Health & Biotech
Check Up: Fundie says ‘buy the dip’ as biotech loses shine amid pandemic rebound
Health & Biotech
Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress
Health & Biotech
ScoPo’s Powerplays: Market volatility creates both buying and selling opportunities in the Health sector
Health & Biotech
As health tech soars, these two ASX medical device plays might have flown under the radar
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
News